Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
暂无分享,去创建一个
[1] A. Dirksen,et al. Airways obstruction and two year survival in patients with severe alpha 1-antitrypsin deficiency. , 1994, The European respiratory journal.
[2] A. Dirksen,et al. American Thoracic Society/European Respiratory Society: Standards in Diagnostik und Therapie bei Patienten mit Alpha-1-Antitrypsin-Mangel , 2005 .
[3] R. Stockley,et al. Modification of gene expression and increase in alpha1-antitrypsin (alpha1-AT) secretion after homologous recombination in alpha1-AT-deficient monocytes. , 2007, Human gene therapy.
[4] C. Laurell,et al. The polymorphism of "prealbumins" and alpha-1-antitrypsin in human sera. , 1967, Clinica chimica acta; international journal of clinical chemistry.
[5] D. Lomas,et al. Alpha1-antitrypsin deficiency--a model for conformational diseases. , 2002, The New England journal of medicine.
[6] American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. , 2003, American journal of respiratory and critical care medicine.
[7] F. Serres. Worldwide Racial and Ethnic Distribution of α1-Antitrypsin Deficiency: Summary of an Analysis of Published Genetic Epidemiologic Surveys , 2002 .
[8] C. Larsson. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. , 2009, Acta medica Scandinavica.
[9] C. Vogelmeier,et al. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. , 2007, Respiratory medicine.
[10] R. Crystal,et al. Molecular basis of alpha-1-antitrypsin deficiency. , 1988, The American journal of medicine.
[11] Pulmonary emphysema and alpha 1-antitrypsin deficiency. , 1968, The American journal of medicine.
[12] Shirley A. Miller,et al. Distribution of α1-Antitrypsin Variants in a US White Population , 1984 .
[13] B. Portmann,et al. Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantion , 2000 .
[14] J. Stoller,et al. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. , 1994, Cleveland Clinic journal of medicine.
[15] T Sveger,et al. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. , 1976, The New England journal of medicine.
[16] R. Crystal,et al. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. , 1981, The Journal of clinical investigation.
[17] D. Parham,et al. Cholangiocarcinoma in two siblings with emphysema and alpha-1-antitrypsin deficiency. , 1989, The Quarterly journal of medicine.
[18] K. Morgan,et al. Gene regulation of the serine proteinase inhibitors α1-antitrypsin and α1-antichymotrypsin , 2001 .
[19] Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. , 1997, Bulletin of the World Health Organization.
[20] T. Sveger,et al. The liver in adolescents with α‐antitrypsin deficiency , 1995 .
[21] H. Levison,et al. Emphysema of early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes). , 1988, The American review of respiratory disease.
[22] J. Jeppsson. Amino acid substitution Glu→Lys in α1‐antitrypsin PiZ , 1976 .
[23] T. Sveger,et al. The liver in adolescents with alpha 1-antitrypsin deficiency. , 1995, Hepatology.
[24] R. Stockley,et al. Predictors of mortality in α1-antitrypsin deficiency , 2003, Thorax.
[25] A. Boutten,et al. Oncostatin M is a potent stimulator of alpha1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor-beta and interferon-gamma. , 1998, American journal of respiratory cell and molecular biology.
[26] F. D. de Serres,et al. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. , 2002, Chest.
[27] C. Laurell,et al. The polymorphism of “prealbumins” and α1-antitrypsin in human sera , 1967 .
[28] R. Stockley,et al. Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development , 2007, European Respiratory Journal.
[29] J. Sugar,et al. Involvement of Sp1 Elements in the Promoter Activity of the α1-Proteinase Inhibitor Gene* , 1998, The Journal of Biological Chemistry.
[30] C. Tinelli,et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency , 2005, Journal of Medical Genetics.
[31] S. Eriksson,et al. PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY. , 2009, Acta medica Scandinavica.
[32] F. D. de Serres,et al. Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries , 2006, European Respiratory Journal.
[33] C. Lenfant,et al. Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .
[34] D. Johnson,et al. The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. , 1979, The Journal of biological chemistry.
[35] J. Dijkman,et al. A matched-pair study of the leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha 1-antitrypsin deficiency. , 1980, The American review of respiratory disease.
[36] S. Breit,et al. Genetic study of a family with two members with Weber Christian disease (panniculitis) and alpha 1 antitrypsin deficiency. , 1982, American journal of medical genetics.
[37] T. Mcneil,et al. Young adults with α1antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high‐risk condition , 1997, Acta paediatrica.
[38] R. Stockley,et al. Modification of Gene Expression and Increase in α1-Antitrypsin (α1-AT) Secretion After Homologous Recombination in α1-AT-Deficient Monocytes , 2007 .
[39] J. Stoller. Erratum: ATS/ERS Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency (American Journal of Respiratory and Critical Care Medicine (835)) , 2004 .
[40] K. Kurachi,et al. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. , 1984, Biochemistry.
[41] N. Seersholm,et al. Clinical features and prognosis of life time non-smokers with severe α1-antitrypsin deficiency , 1998, Thorax.
[42] A. Boutten,et al. Oncostatin M Is a Potent Stimulator of α1-Antitrypsin Secretion in Lung Epithelial Cells: Modulation by Transforming Growth Factor- β and Interferon- γ , 1998 .
[43] S. Ikemoto,et al. Deletion 14q(q24.3 to q32.1) syndrome: significance of peculiar facial appearance in its diagnosis, and deletion mapping of (α1-antitrypsin) , 1986, Human Genetics.
[44] M. Schluchter,et al. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. , 1996, American journal of respiratory and critical care medicine.
[45] D. Hutchison. Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z. , 1998, Respiratory medicine.
[46] D. Lomas,et al. Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. , 2005, The American journal of pathology.
[47] W. B. Hunt,et al. Pulmonary emphysema and alpha-1 antitrypsin deficiency. , 1972, Virginia medical monthly.
[48] C. Laurell,et al. The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency , 1963 .